Sign in

CIK 0001785530 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

Werewolf Therapeutics, Inc.

Sign in to watch
Ticker
HOWL
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
823523180
Phone
617-952-0555
Business address
303 WYMAN STREET, SUITE 300, WALTHAM, MA, 02451
  1. 144 Insider Sale of Securities
  2. 144 Insider Sale of Securities
  3. 144 Insider Sale of Securities
  4. 10-Q Report Quarterly Report
  5. 8-K Event Results of operations
  6. 4 Planned sale Director sold 189,356 shares at an average $1.33 ($251,349)
  7. 4 Planned sale 10% owner sold 295,043 shares at an average $1.33 ($391,636)
  8. 4 Planned sale 10% owner sold 295,043 shares at an average $1.33 ($391,636)
  9. 144 Insider Sale of Securities
  10. 144 Insider Sale of Securities
  11. 144 Insider Sale of Securities
  12. 144 Insider Sale of Securities
  13. 144 Insider Sale of Securities
  14. 144 Insider Sale of Securities
  15. 4 Planned sale Director sold 177,145 shares at an average $1.62 ($286,497)
  16. 4 Planned sale 10% owner sold 276,017 shares at an average $1.62 ($446,403)
  17. 4 Planned sale 10% owner sold 276,017 shares at an average $1.62 ($446,403)
  18. 144 Insider Sale of Securities
  19. 144 Insider Sale of Securities
  20. 144 Insider Sale of Securities

Page 10 of 23 · 453 filings